Subclinical Myocardial Injury and Risk of COVID-19 in the General Population: The Trøndelag Health Study
Clin Chem
.
2022 Mar 4;68(3):473-475.
doi: 10.1093/clinchem/hvab267.
Authors
Magnus Nakrem Lyngbakken
1
2
,
Kristian Hveem
3
4
,
Helge Røsjø
2
5
,
Torbjørn Omland
1
2
Affiliations
1
Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.
2
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
3
HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Norway.
4
Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.
5
Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway.
PMID:
34878096
PMCID:
PMC9383106
DOI:
10.1093/clinchem/hvab267
No abstract available
Keywords:
cardiac markers; epidemiology studies; troponin; viral diseases.
MeSH terms
Biomarkers
COVID-19* / epidemiology
Heart Injuries* / epidemiology
Humans
Norway / epidemiology
SARS-CoV-2
Troponin I
Substances
Biomarkers
Troponin I
Grants and funding
Abbott Diagnostics